State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$2.01B |
| 2 |
Microsoft
MSFT
|
+$1.38B |
| 3 |
NVIDIA
NVDA
|
+$1.2B |
| 4 |
Apple
AAPL
|
+$1.06B |
| 5 |
Amazon
AMZN
|
+$1.02B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$1.87B |
| 2 |
ExxonMobil
XOM
|
+$656M |
| 3 |
Chevron
CVX
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$569M |
| 5 |
X
US Steel
X
|
+$382M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.32% |
| 2 | Financials | 14.17% |
| 3 | Consumer Discretionary | 9.89% |
| 4 | Healthcare | 9.66% |
| 5 | Industrials | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Inhibikase Therapeutics
IKT
$347M
| $776K | ﹤0.01% |
397,812
+355,928
| +850% | +$697K |
|
3352
HireQuest
HQI
$190M
| $774K | ﹤0.01% |
77,359
+1,611
| +2% | +$16.5K |
|
3353
Lexicon Pharmaceuticals
LXRX
$1.03B
| $774K | ﹤0.01% |
818,621
-1,788,953
| -69% | -$1.16M |
|
3354
Hanover Bancorp
HNVR
$190M
| $773K | ﹤0.01% |
+33,786
| New | +$740K |
|
3355
Lineage Cell Therapeutics
LCTX
$264M
| $771K | ﹤0.01% |
849,522
-1,800,664
| -68% | -$1.07M |
|
3356
Sagimet Biosciences
SGMT
$435M
| $760K | ﹤0.01% |
99,800
| – | – |
|
3357
Prairie Operating Co
PROP
$68.4M
| $759K | ﹤0.01% |
253,299
+151,658
| +149% | +$607K |
|
3358
Greenwich LifeSciences
GLSI
$188M
| $746K | ﹤0.01% |
82,247
+7,039
| +9% | +$67K |
|
3359
Myomo
MYO
$35.9M
| $738K | ﹤0.01% |
341,825
+246,850
| +260% | +$895K |
|
3360
Mercer International
MERC
$40.5M
| $734K | ﹤0.01% |
205,213
+11,400
| +6% | +$47.2K |
|
|
SWKH
3361
DELISTED
SWK Holdings
SWKH
| $732K | ﹤0.01% |
49,657
-11,243
| -18% | -$159K |
|
3362
Geospace Technologies
GEOS
$84M
| $730K | ﹤0.01% |
51,189
-107,427
| -68% | -$802K |
|
|
ONL
3363
Orion Office REIT
ONL
$151M
| $727K | ﹤0.01% |
338,120
-997,499
| -75% | -$1.9M |
|
3364
ORIX
IX
$42.7B
| $724K | ﹤0.01% |
32,135
| – | – |
|
3365
Lucid Diagnostics
LUCD
$175M
| $717K | ﹤0.01% |
623,068
+578,087
| +1,285% | +$747K |
|
|
BZAI
3366
Blaize Holdings
BZAI
$108M
| $716K | ﹤0.01% |
240,270
+158,120
| +192% | +$389K |
|
|
AVR
3367
Anteris Technologies
AVR
$769M
| $715K | ﹤0.01% |
188,715
+99,911
| +113% | +$406K |
|
3368
Nice
NICE
$6.15B
| $701K | ﹤0.01% |
4,148
| – | – |
|
3369
Structure Therapeutics
GPCR
$3.37B
| $694K | ﹤0.01% |
33,459
+22,719
| +212% | +$500K |
|
3370
Alpha Teknova
TKNO
$266M
| $688K | ﹤0.01% |
140,107
+71,462
| +104% | +$421K |
|
3371
Betterware México
BWMX
$632M
| $687K | ﹤0.01% |
79,394
+1,792
| +2% | +$16.7K |
|
|
DFDV
3372
DeFi Development Corp
DFDV
$77.4M
| $684K | ﹤0.01% |
+35,112
| New | +$505K |
|
|
PPIH
3373
Perma-Pipe International
PPIH
$189M
| $674K | ﹤0.01% |
29,468
| – | – |
|
3374
Lightwave Logic
LWLG
$824M
| $674K | ﹤0.01% |
543,269
-1,938,279
| -78% | -$2.04M |
|
|
ABX
3375
Abacus Global Management
ABX
$988M
| $668K | ﹤0.01% |
129,930
+55,230
| +74% | +$408K |
|
Similar funds
State Street's Q2 2025 Portfolio in Review
As of Q2 2025, State Street held 4,369 positions worth $2.67T, up 9.9% from $2.43T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.5%. State Street opened 86 new positions and exited 109, leaving the 4,369-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
- State Street's largest Q2 2025 buy was Ralliant Corp: 4,394,640 shares worth $213M.
- State Street added most to Capital One in Q2 2025, an estimated $2.01B increase.
- State Street's biggest Q2 2025 reduction was ExxonMobil, cutting an estimated $656M.
- State Street fully exited Discover Financial Services in Q2 2025, selling an estimated $1.87B.
- State Street's ten largest holdings make up 29% of its $2.67T portfolio in Q2 2025.
- State Street opened 86 new positions and closed 109 in Q2 2025.
- State Street's portfolio value rose 9.9% quarter-over-quarter to $2.67T.
Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.